The review assessed the effectiveness and cost-effectiveness of diagnostic methods for urinary incontinence, specifically urodynamic stress incontinence and detrusor overactivity. The authors put forward a number of conclusions, which are likely to be reliable.
The quality of the primary papers was assessed using the Quality Assessment of Diagnostic Accuracy Studies (QUADAS) tool. Additional instructions were added to ensure consistency between assessors. Seven reviewers were involved in the validity assessment; two different reviewers assessed a sample (16 of 121) of the papers to test interreader agreement. The agreement between reviewers ranged from 0.50 to 1.00. Any disagreements were resolved by consensus.
Data extraction
Members of the project team extracted details including size, gender and age of sample, as well as care setting and country. Where additional information was required, the authors of the primary studies were contacted.
Methods of synthesis
How were the studies combined? Studies of the same diagnostic procedure using the same cut-off threshold were pooled using random-effects models. Summary estimates were presented as sensitivity, specificity and diagnostic odds ratio (DOR), along with their associated 95% confidence intervals (CIs). The positive likelihood ratio was calculated from the pooled specificity and sensitivity. Where a quantitative analysis was not appropriate, a narrative synthesis was presented.
How were differences between studies investigated?
Statistical heterogeneity was assessed using chi-squared tests. For each type of test, the studies were grouped by type of urinary incontinence (USI or DO) and gender.
Results of the review
One hundred and twenty-nine studies were included in the review.
Of the included papers: 84% reported an appropriate reference standard; 86% reported that individuals received the same reference standard regardless of the index test result; 77% reported that the two diagnostic tests were independent of each other; 91% reported that the whole sample or a random selection of the whole sample received verification using a reference standard of diagnosis; 39% did not adequately report the selection criteria used; it was unclear whether 79% of the reference tests and 83% of the index tests were interpreted without knowledge of the other test; 67% did not report withdrawals; 64% did not report the duration between the two diagnostic tests; 64% included a representative spectrum of patients; 64% of the index tests and 59% of the reference tests were described sufficiently for replication; and 79% provided the same clinical data as would be available in clinical practice.
Clinical history when compared with urodynamics (presence or absence of stress incontinence symptoms) for diagnosing USI in women was found to have a pooled sensitivity of 0.92 (95% CI: 0.91, 0.93) and a pooled specificity of 0.56 (95% CI: 0.53, 0.60), based on 15 studies. Significant heterogeneity was found for both analyses (p<=0.001 and p<=0.001). The positive likelihood ratio was 2.09 (95% CI: 1.83, 2.35) and the area under the curve (AUC) for the receiver operating characteristic (ROC) curve for the pooled DOR was 0.83 (95% CI: 0.71, 0.95). For diagnosing DO in women, a pooled sensitivity of 0.61 (95% CI: 0.57, 0.65) and a pooled specificity of 0.87 (95% C: 0.85, 0.89) were found, based on 8 studies. Significant heterogeneity was found for both analyses (p<=0.001 and p<=0.001). The positive likelihood ratio was 4.69 (95% CI: 4.05, 5.33) and the AUC for the ROC curve for the pooled DOR was 0.83 (95% CI: 0.69, 0.97). Three studies considered clinical history for diagnosing DO in men; the sensitivity ranged from 0.50 to 1.00 and the specificity from 0.50 to 0.77.
Validated scales (based on question 3 of the Urogenital Distress Inventory) compared with urodynamics were found to have a pooled sensitivity of 0.87 (95% CI: 0.82, 0.92) and a pooled specificity of 0.60 (95% CI: 0.51, 0.69), based on 2 studies. No significant heterogeneity was found.
Seven studies compared pad tests with multichannel urodynamics. The sensitivity ranged from 0.86 to 0.94 and the specificity from 0.44 to 0.72; estimates were not pooled because there were insufficient studies comparing the same pad tests or reporting adequate data.
Urinary diary compared with urodynamics for diagnosing DO in women was found to have a sensitivity of 0.88 (95% CI: 0.71, 0.96) and a specificity of 0.83 (95% CI: 0.77, 0.87), based on 1 study.
Imaging by ultrasound to determine leakage in the diagnosis of USI in women was found to have a pooled sensitivity of 0.89 (95% CI: 0.84, 0.93), based on 4 studies; significant heterogeneity was found (p=0.004). The pooled specificity was 0.82 (95% CI: 0.73, 0.89; 4 studies); no significant heterogeneity was found.
X-ray to image bladder neck descent compared with multichannel urodynamics for diagnosing USI was found to have a sensitivity of 0.79 (95% CI: 0.67, 0.88) and a specificity of 0.55 (95% CI: 0.43, 066), based on 2 studies. Significant heterogeneity was found for specificity only (p<=0.001). The positive likelihood ratio was 1.76 (95% CI: 0.90, 2.61).
Six studies compared stress test with multichannel urodynamics, of which three were pooled. A sensitivity of 0.85 (95% CI: 0.78, 0.91) and a specificity of 0.83 (95% CI: 0.74, 0.90) were found for diagnosing USI in women in secondary care settings using the supine stress test compared with multichannel urodynamics. No significant heterogeneity was found. The positive likelihood ratio was 5.00 (95% CI: 3.79, 6.21), and the AUC for the ROC curve corresponding to the pooled DOR was 0.87 (95% CI: 0.69, 1.00).
Additional results for other comparators were also presented. No studies met the inclusion criteria for the diagnosis of bladder outlet obstruction.
Cost information
Urinary diary had the lowest cost-effectiveness ratio (between £35 and £77) per extra unit of effectiveness, or case diagnosed, of three primary care tests (diary, pad tests and validated scales) in addition to clinical history.
